This form predicts the probability of post-PCI MVO occurrence based on preoperative information.
Fill in the patient's preoperative details to get the prediction.
High-Sensitivity Troponin T (hs-TnT) is a cardiac biomarker measured in nanograms per liter (ng/L). It assesses troponin levels in the blood, providing sensitive detection of heart muscle damage.
Neutrophil Count (NEUT) is measured in billions of cells per liter (10^9 cells/L). It refers to the number of neutrophils, a type of white blood cell, in the bloodstream, serving as an indicator of the body's immune response.
Creatine Kinase-MB (CK-MB) is an enzyme measured in nanograms per milliliter (ng/mL) and is released during heart muscle injury, aiding in the diagnosis of myocardial infarction.
Fibrinogen (Fib) is a protein measured in grams per liter (g/L) involved in blood clot formation and can be measured to assess the risk of cardiovascular events.
Left Ventricular Ejection Fraction (LVEF) represents the percentage of blood pumped out of the left ventricle of the heart with each contraction, measured in percentage (%), serving as a key parameter in evaluating cardiac function.
The values of hs-TnT and CK-MB are selected based on peak levels measured in patients during hospitalization.
These parameters are collected preoperatively and are utilized to assess the risk of microvascular obstruction (MVO) occurrence in patients undergoing percutaneous coronary intervention (PCI) procedures.